Net Sales
Breakdown
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Cardiovascular | $3.2B | $3.0B | $3.1B | $3.0B | $3.7B | $3.3B | $3.4B | $3.5B |
| Neuroscience | $2.4B | $2.3B | $2.5B | $2.5B | $2.5B | $2.4B | $2.6B | $2.6B |
| Medical Surgical | $2.0B | $2.0B | $2.1B | $2.1B | $2.2B | $2.1B | $2.2B | $2.2B |
| Diabetes Group | $693.0M | $647.0M | $686.0M | $694.0M | $784.0M | $721.0M | $757.0M | $796.0M |
| Other operating segment | — | — | — | $32.0M | $36.0M | $33.0M | $35.0M | $32.0M |
| Total | $8.2B | $7.9B | $8.4B | $8.3B | $9.2B | $8.6B | $9.0B | $9.0B |
Other Segment is derived from annual filings.
Segments
Other operating segmentView metric
NeuroscienceView metric
Medical SurgicalView metric
Reportable segment net salesView metric
Diabetes GroupView metric
CardiovascularView metric
Other SegmentView metric